Literature DB >> 1825222

Analysis of the structure and expression of the human dopamine D2A receptor gene.

K Y Gandelman1, S Harmon, R D Todd, K L O'Malley.   

Abstract

In order to study the possible involvement of dopamine receptors in the pathophysiology of various neurological and psychiatric disorders, we have isolated the human D2A gene. Like the rat D2A gene, the human gene contains at least eight exons and spans at least 52 kb. Exons 2-8 are clustered within 14 kb of genome. Exon 1 is separated from exon 2 by at least 38 kb. We and others have shown that alternative utilization of exon 6 gives rise to alternative D2A transcripts. Despite the extreme size of intron 1, no alternative transcription between exons 1 and 2 can be detected in basal ganglia and pituitary using polymerase chain reaction analysis. The relative abundance and tissue distribution of the alternative D2A transcripts were examined in 18 human brain regions. The relative expression of the transcripts varied by at least 70-fold across the brain regions surveyed. As expected, high levels of transcripts were detected in caudate, putamen, and pituitary. Moderate levels were detected in regions of catecholamine-containing cell bodies and in the amygdala. In contrast to the rat brain, very low levels of transcripts were detected in cortical regions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825222     DOI: 10.1111/j.1471-4159.1991.tb02024.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

3.  Dopamine D2 receptor gene expression in human adenohypophysial adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; M Buchfelder; R Fahlbusch; L Lancranjan
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

4.  Characterization of the 5' flanking region of the human D1A dopamine receptor gene.

Authors:  M T Minowa; T Minowa; F J Monsma; D R Sibley; M M Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Associations Between Dopamine D2 Receptor (DRD2) Gene, Maternal Positive Parenting and Trajectories of Depressive Symptoms from Early to Mid-Adolescence.

Authors:  Cong Cao; Jolien Rijlaarsdam; Anja van der Voort; Linqin Ji; Wenxin Zhang; Marian J Bakermans-Kranenburg
Journal:  J Abnorm Child Psychol       Date:  2018-02

6.  An Alu polymorphism intragenic to the TP53 gene.

Authors:  P A Futreal; J C Barrett; R W Wiseman
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

7.  A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2).

Authors:  A Parsian; L Fisher; K L O'Malley; R D Todd
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

8.  Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.

Authors:  Leonardo Vieira Neto; Evelyn de O Machado; Raul M Luque; Giselle F Taboada; Jorge B Marcondes; Leila M C Chimelli; Leonardo Pereira Quintella; Paulo Niemeyer; Denise P de Carvalho; Rhonda D Kineman; Mônica R Gadelha
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

9.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

Authors:  Ying Zhang; Alessandro Bertolino; Leonardo Fazio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Mei-Ling T Lee; Tao Xiao; Audrey Papp; Danxin Wang; Wolfgang Sadée
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

10.  Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Authors:  T A Reader; E Molina-Holgado; K M Dewar
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.